DATA UNION CAP (08375) enters into a primary sales agreement with Guangzhou Zhengye Electronic Technology.
SumTiger Capital (08375) announced that on May 22, 2026, after fair negotiation between the two parties, its indirect wholly-owned subsidiary, Decheng, entered into a main sales agreement with the buyer, Guangzhou Zhengye Electronic Technology Co., Ltd. The agreement involves Decheng selling electronic components and hardware products to the buyer from the effective date until December 31, 2028 (including the first and last day).
DATA UNION CAP(08375) announced that on May 22, 2026, after fair negotiations between both parties, its indirect wholly-owned subsidiary, Decheng, entered into a principal sales agreement with the buyer Guangzhou Zhengye Electronic Technology Co., Ltd. The agreement concerns Decheng selling electronic components and hardware products to the buyer, effective from the date of effect until December 31, 2028 (including the first and last days).
The subject matter is based on the terms and conditions of the principal sales agreement, as well as specific purchase orders to be entered into by Decheng and the buyer. Decheng agrees to sell, and the buyer agrees to purchase, electronic components and hardware products manufactured or procured by Decheng, including but not limited to integrated circuits, semiconductors (such as diodes and transistors), charging equipment, LED lighting products, and LED displays and screens (collectively referred to as "Products"). Decheng will also provide value-added services to the buyer free of charge, including evaluating related suppliers and manufacturers, order tracking, after-sales services, and providing monthly or quarterly reports containing data records and analysis of the buyer's purchases under the principal sales agreement.
The company believes that entering into the principal sales agreement is in the overall interest of the company and its shareholders, as selling products to the buyer will increase the group's sales revenue and further strengthen the performance of the group's electronic components and hardware trading business.
Related Articles

Zhejiang Meili High Technology (300611.SZ) plans to repurchase company shares with an amount ranging from 40 million to 70 million yuan.

IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.
Zhejiang Meili High Technology (300611.SZ) plans to repurchase company shares with an amount ranging from 40 million to 70 million yuan.

IMOTIONTECH (01274) spent 1.77 million Hong Kong dollars to repurchase 385,500 shares on May 22nd.

CSPC PHARMA (01093): Ulinastatin Injection Obtains Approval from National Medical Products Administration for Market Launch.






